Research GradeGHRH Analogue · 1-2-Day Delivery to Leeds
A synthetic GHRH analogue with a trans-3-hexenoic acid modification. FDA-approved (as Egrifta) for HIV-associated lipodystrophy, Tesamorelin is studied for its potent GH stimulation and visceral fat reduction properties.
Tesamorelin is a synthetic GHRH analogue with a trans-3-hexenoic acid group attached to the tyrosine at position 1. This modification confers greater potency and stability than native GHRH. It stimulates pituitary GH release through GHRH receptors, with particular efficacy in reducing visceral adipose tissue.
Peptides Pharma delivers Tesamorelin research vials directly to Leeds with 1-2-day tracked delivery. Order online at peptidespharma.com and receive your research-grade lyophilized vial at your door.
Peptides Pharma Tesamorelin is priced at €69 per vial, which contains a 30-day supply of 2mg in a pre-mixed, ready-to-use vial system. Free UK delivery on orders over €175.
Yes, Tesamorelin is legal to purchase for research purposes in Leeds and across the UK. Peptides Pharma products are sold strictly for research use only.
Peptides Pharma Tesamorelin exceeds 99% purity, verified by independent HPLC analysis. Each batch comes with a Certificate of Analysis from a third-party laboratory.
Both are GHRH analogues, but Tesamorelin includes the full 44-amino acid GHRH sequence with an N-terminal trans-3-hexenoic acid modification. This makes it more potent and stable than Sermorelin (GHRH 1-29). Tesamorelin also has FDA approval for lipodystrophy.
Clinical trials demonstrated specific reduction in visceral adipose tissue (VAT) — the metabolically dangerous deep abdominal fat — while preserving subcutaneous fat and lean tissue. This selective effect is relatively unique among GH-axis compounds.
1-2-day tracked delivery. Pre-mixed & ready to use. >99% purity guaranteed.
ORDER TESAMORELIN — €69
